Physiologic Effects of Continuous Positive Airway Pressure and High Flow Nasal Oxygenation in Patients with Acute Respiratory Distress Syndrome.

NARecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 7, 2025

Primary Completion Date

April 30, 2026

Study Completion Date

July 31, 2027

Conditions
Acute Respiratory Distress Syndrome (ARDS)Acute Respiratory Failure with Hypoxia
Interventions
DEVICE

CPAP

"12 cmH2O for 48 hours (at least 10 hours of therapy per day). Nasobucal interface will be the preferred route with complete facial mask being also an acceptable device. If needed, therapy breaks will be delivered with HFNO at 50 L/min.~Non-invasive ventilation will not be allowed.~After 48 hours of treatment, clinicians will be able to decide the respiratory support to be provided although CPAP will be recommended to be continued as long as PaO2/FiO2 is less than or equal to 300 and inspired oxygen fraction is 40% or more."

DEVICE

HFNO 50 L/min

"HFNO 50 L/min for 48 hours. Therapy breaks with oxygen facemask will be allowed as per clinician decision but the protocol will advise against this practice.~Non-invasive ventilation will not be allowed.~After 48 hours of treatment, clinicians will be able to decide the respiratory support to be provided although HFNO will be recommended to be continued as long as PaO2/FiO2 is less than or equal to 300 and inspired oxygen fraction is 40% or more."

Trial Locations (1)

08036

RECRUITING

Hospital Clínic de Barcelona, Barcelona

All Listed Sponsors
collaborator

Hospital Clinic of Barcelona

OTHER

collaborator

Spanish Society of Pneumology and Thoracic Surgery

OTHER

lead

Ricard Mellado Artigas

OTHER